Coastal Bridge Advisors, LLC
Position in MLYS — Mineralys Therapeutics, Inc.
CIK 1665976
WESTPORT, CT
Position in MLYS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$66,101
New position
Shares Held
2,450
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#173
of 224 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Derivatives in MLYS
reported options exposure · as of Jun 30, 2026CallValue
$7,900
CallShares
20,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Coastal Bridge Advisors, LLC holds $11,640,553 across 14 Biotechnology names. MLYS ranks #12 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
276,817 | $2,743,256 | |
| 2 | INCY |
Incyte Corp
|
21,815 | $2,472,948 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
37,000 | $1,361,600 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
3,846 | $1,287,602 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
14,500 | $1,134,915 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,614 | $1,006,393 | |
| 7 | SPRY |
ARS Pharmaceuticals, Inc.
|
55,838 | $447,262 | |
| 8 | BHVN |
Biohaven Ltd.
|
23,022 | $342,567 |
All Filings in MLYS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,900 | 20,000 | Call | Sole | 2026-08-17 | |
| 2026-06-30 | $66,101 | 2,450 | Shares | Sole | 2026-08-17 | |
| No filing history on record for this holder in this stock. | ||||||